BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...Plus: management moves at Phagelux, Chiesi, Kanova and Oyster Point By Danielle Golovin, Staff Writer David Ricks has...
...was head of strategy and investor relations at Cellular Biomedicine Group Inc. (NASDAQ:CBMG).Phage-based antibacterial company Phagelux Inc....
...School of Medicine. Carlson was EVP and CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux Inc. Chiesi...
BioCentury | Jan 4, 2018
Company News

Management tracks: Acceleron, Selecta

...Biosimilars company JHL Biotech Inc. (TPEx-E:6540) hired Rong Chen as CMO. He was CMO at Phagelux Inc....
BioCentury | Apr 14, 2017
Company News

Phagelux, Johnson & Johnson deal

...consumer unit of Johnson & Johnson to develop one or more antibacterial skin care products. Phagelux...
...Phagelux Inc. , Shanghai, China Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious Chris Lieu Johnson & Johnson Phagelux Inc....
BioCentury | Apr 12, 2017
Company News

Phagelux, J&J in antibacterial deal

...unit of Johnson & Johnson (NYSE:JNJ) to develop one or more antibacterial skin care products. Phagelux...
...Innovation unit facilitated the deal. Phagelux is developing phage and lysin antibacterial products. Chris Lieu Johnson & Johnson Phagelux Inc....
BioCentury | Feb 15, 2016
Financial News

Phagelux completes venture financing

Phagelux Inc. , Shanghai, China Business: Infectious, Veterinary, Agbio/Environmental Date completed: 2016-02-05 Type: Venture financing Raised: Not disclosed Investor: Fosun Pharma Note: The amount raised is not disclosed. WIR Staff Infectious...
BioCentury | Nov 16, 2015
Company News

SciThera Microbial Technologies, Phagelux deal

...multiple lysins for pathogen control. Phagelux is developing antibacterial solutions using phage and phage-based technologies. Phagelux...
...could not be reached in time for publication. SciThera Microbial Technologies Inc. , Wuhan, China Phagelux Inc....
BioCentury | Jun 22, 2015
Financial News

Phagelux completes venture financing

Phagelux Inc. , Shanghai, China Business: Infectious, Veterinary, Agbio/Environmental Date completed: 2015-06-08 Type: Venture financing Raised: $10 million Investors: WuXi AppTec; Tianshi Capital; Zongyi Group WIR Staff...
BioCentury | Apr 13, 2015
Company News

Biophage Pharma Inc, Phagelux deal

...Phagelux’s Phagelux Canada Inc. subsidiary will purchase IP and phage and bacterial libraries from Biophage for...
...of up to $250,000 in equity. Biophage expects the deal to close by May 31. Phagelux...
...not respond to inquiries in time for publication. Biophage Pharma Inc . (NEX:BUG), Montreal, Quebec Phagelux Inc....
Items per page:
1 - 8 of 8
BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...Plus: management moves at Phagelux, Chiesi, Kanova and Oyster Point By Danielle Golovin, Staff Writer David Ricks has...
...was head of strategy and investor relations at Cellular Biomedicine Group Inc. (NASDAQ:CBMG).Phage-based antibacterial company Phagelux Inc....
...School of Medicine. Carlson was EVP and CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux Inc. Chiesi...
BioCentury | Jan 4, 2018
Company News

Management tracks: Acceleron, Selecta

...Biosimilars company JHL Biotech Inc. (TPEx-E:6540) hired Rong Chen as CMO. He was CMO at Phagelux Inc....
BioCentury | Apr 14, 2017
Company News

Phagelux, Johnson & Johnson deal

...consumer unit of Johnson & Johnson to develop one or more antibacterial skin care products. Phagelux...
...Phagelux Inc. , Shanghai, China Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious Chris Lieu Johnson & Johnson Phagelux Inc....
BioCentury | Apr 12, 2017
Company News

Phagelux, J&J in antibacterial deal

...unit of Johnson & Johnson (NYSE:JNJ) to develop one or more antibacterial skin care products. Phagelux...
...Innovation unit facilitated the deal. Phagelux is developing phage and lysin antibacterial products. Chris Lieu Johnson & Johnson Phagelux Inc....
BioCentury | Feb 15, 2016
Financial News

Phagelux completes venture financing

Phagelux Inc. , Shanghai, China Business: Infectious, Veterinary, Agbio/Environmental Date completed: 2016-02-05 Type: Venture financing Raised: Not disclosed Investor: Fosun Pharma Note: The amount raised is not disclosed. WIR Staff Infectious...
BioCentury | Nov 16, 2015
Company News

SciThera Microbial Technologies, Phagelux deal

...multiple lysins for pathogen control. Phagelux is developing antibacterial solutions using phage and phage-based technologies. Phagelux...
...could not be reached in time for publication. SciThera Microbial Technologies Inc. , Wuhan, China Phagelux Inc....
BioCentury | Jun 22, 2015
Financial News

Phagelux completes venture financing

Phagelux Inc. , Shanghai, China Business: Infectious, Veterinary, Agbio/Environmental Date completed: 2015-06-08 Type: Venture financing Raised: $10 million Investors: WuXi AppTec; Tianshi Capital; Zongyi Group WIR Staff...
BioCentury | Apr 13, 2015
Company News

Biophage Pharma Inc, Phagelux deal

...Phagelux’s Phagelux Canada Inc. subsidiary will purchase IP and phage and bacterial libraries from Biophage for...
...of up to $250,000 in equity. Biophage expects the deal to close by May 31. Phagelux...
...not respond to inquiries in time for publication. Biophage Pharma Inc . (NEX:BUG), Montreal, Quebec Phagelux Inc....
Items per page:
1 - 8 of 8